ArticleAdvances in therapyPublished
Real-World PSA Response and Overall Survival Among Men with mCSPC Receiving Apalutamide Versus Darolutamide (Both Without Docetaxel) in the US
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Advances in therapy
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Thiohydantoins; Pyrazoles; Pyrrolidines; Prostate-Specific Antigen; Retrospective Studies; Aged; Aged, 80 and over; Middle Aged; United States; Male; Prostatic Neoplasms, Castration-Resistant
- PubMed ID
- 42518140
- PubMed Central ID
- PMC13619676
- Open access
- Yes, open
- Added to directory
- Source checked